Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU
01:11pm, Tuesday, 23'rd Sep 2025
CRISPR Therapeutics and Sirius dose the first patient in a phase II study of SRSD107 for thromboembolic disorders in Europe.
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?
10:01am, Tuesday, 23'rd Sep 2025
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
06:50pm, Wednesday, 17'th Sep 2025
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $59.07, marking a -3.46% move from the previous day.
Crispr Therapeutics: Why Stock Fell On Q2 Earnings, And Why We're Now Back On Track
04:09pm, Wednesday, 17'th Sep 2025
Crispr Therapeutics AG remains undervalued despite recent stock volatility and slow Casgevy commercial uptake, with long-term potential intact. Casgevy's strong clinical data and broad approvals are t
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 12'th Sep 2025
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wall Street Analysts See CRISPR Therapeutics (CRSP) as a Buy: Should You Invest?
10:31am, Thursday, 11'th Sep 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190%
03:45am, Thursday, 11'th Sep 2025
Cathie Wood is known for seizing opportunities. The founder of Ark Invest doesn't worry when one of the stocks she's invested in drops, and instead, she looks at the movement as a chance to increase h
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Wednesday, 10'th Sep 2025
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $51.81, indicating a -3.5% shift from the previous trading day.
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
04:00pm, Tuesday, 09'th Sep 2025
ZUG, Switzerland and BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious dise
CRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
11:38am, Tuesday, 09'th Sep 2025
CRISPR Therapeutics AG (NASDAQ:CRSP ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 8:30 AM EDT Company Participants Samarth Kulkarni - CEO & Chairman Conference Call Parti
CRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference Transcript
06:53am, Tuesday, 09'th Sep 2025
CRISPR Therapeutics AG (NASDAQ:CRSP ) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT Company Participants Raju Prasad - Chief Financial Officer Conference Call
Crispr Therapeutics: A Winning Lottery Ticket Doesn't Replace Grand Strategy
08:55am, Tuesday, 02'nd Sep 2025
CRISPR stock is a bold investment in the future. Beyond the valuation, thematically and based on current market dynamics, I consider this a venture-style winner. Just because CRISPR stock may be a win
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 02'nd Sep 2025
ZUG, Switzerland and BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious d
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 01'st Sep 2025
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
1 Reason Every Investor Should Know About CRISPR Therapeutics (CRSP)
04:21pm, Friday, 29'th Aug 2025
Small biopharma story stocks just aren't paying off like they used to. Maybe there are just too many of them, with each one working on a medical breakthrough that's statistically unlikely to even come
